Mapping Drug Dose Distribution on CT Images Following Transarterial Chemoembolization with Radiopaque Drug-Eluting Beads in a Rabbit Tumor Model

Abstract

Purpose To correlate bead location and attenuation on CT images with the quantity and distribution of drug delivered to the liver following transarterial chemoembolization (TACE) with radiopaque drug-eluting beads (DEB) in a rabbit tumor model. Materials and Methods All procedures were performed with a protocol approved by the Institutional Animal Care and Use Committee. TACE was performed in rabbits (n = 4) bearing VX2 liver tumors by using radiopaque DEB (70-150 µm) loaded with doxorubicin (DOX). Livers were resected 1 hour after embolization, immediately frozen, and cut by using liver-specific three-dimensional-printed molds for colocalization of liver specimens and CT imaging. DOX penetration into tissue surrounding beads was evaluated with fluorescence microscopy. DOX levels in liver specimens were predicted by using statistical models correlating DOX content measured in tissue with bead volume and attenuation measured on CT images. Model predictions were then compared with actual measured DOX concentrations to assess the models' predictive power. Results Eluted DOX remained in close proximity (<600 µm) to beads in the liver 1 hour after TACE. Bead volume and attenuation measured on CT images demonstrated positive linear correlations (0.950 and 0.965, respectively) with DOX content in liver specimens. DOX content model predictions based on CT images were accurate compared with actual liver DOX levels at 1 hour. Conclusion CT may be used to estimate drug dose delivery and distribution in the liver following transarterial chemoembolization (TACE) with doxorubicin-loaded radiopaque drug-eluting beads (DEB). Although speculative, this informational map might be helpful in planning and understanding the spatial effects of TACE with DEB. © RSNA, 2018.

<p>Transcatheter Intra-Arterial Infusion Combined with Interventional Photothermal Therapy for the Treatment of Hepatocellular Carcinoma</p>

“…Rabbit hepatic VX2 carcinoma is a rapidly growing, hypervascular tumor that is mainly vascularized by the hepatic artery, similar to human hepatocellular carcinoma; thus, the hepatic VX2 carcinoma model has been increasingly used in recent years as a model for both HCC and interventional therapies. [37][38][39] In this study, after 2 weeks of tumor implantation, a superselective hepatic arteriogram showed obvious staining of the tumor in the left lobe of the liver and a rich blood supply (Figure 2A and C). After the injection of Bi-Ln NPs (Figure 2B), X-ray fluoroscopic images showed obvious Bi-Ln NPs aggregation in the tumor area.…”

The efficacy of drug‐eluting beads bronchial arterial chemoembolization loaded with gemcitabine for treatment of non‐small cell lung cancer

“…Meanwhile, slow release of an antitumor drug by the DEB‐BACE method can increase the local tumor drug concentration and drug retention time, whilst reducing the systemic drug concentration . DEB‐BACE can therefore provide a more constant antitumor drug concentration in local tumor tissues, resulting in more effective tumor necrosis, thereby alleviating clinical symptoms and improving the treatment response . Xiang et al .…”

Radiologic-Pathologic Analysis of Increased Ethanol Localization and Ablative Extent Achieved by Ethyl Cellulose

“…Both magnetic resonance imaging [32] and CT [23] allow 3D visualization of injected ethanol, with CT imaging lending itself to easier quanti cation arising from diminished soft tissue contrast and imaging eld gradients as noise sources [33]. CT imaging has previously been demonstrated to exhibit strong predictive ability in mapping drug dose distribution following trans-arterial chemoembolization [34]. Utilizing ethanol-water mixtures as in vitro tissue surrogates in this study, ethanol demonstrated a linear relationship between radiodensity and ethanol concentration [23] to segment a cytotoxic delivery threshold as the slight non-linearity introduces an error of 7.7%.…”